Peramivir and laninamivir susceptibility of circulating influenza A and B viruses
Sook-Kwan Leang, Simon Kwok, Sheena G Sullivan, Sebastian Maurer-Stroh, Anne Kelso, Ian G Barr, Aeron C Hurt
INFLUENZA AND OTHER RESPIRATORY VIRUSES | WILEY | Published : 2014
Awarded by A*STAR Singapore
The authors thank all the laboratories that submit specimens and isolates to the Melbourne WHO CCRRI for antiviral sensitivity testing. Peramivir (BCS-1812) was kindly provided by BioCryst Pharmaceuticals Inc, NC, USA and, laninamivir (R-125489) was kindly provided by Daiichi-Sankyo, Tokyo, Japan. The Melbourne WHO Collaborating Centre for Reference and Research on Influenza is supported by the Australian Government Department of Health and Ageing. This work was partially supported by the Australian NHMRC and A*STAR Singapore through the joint grant 12/1/06/24/5793 to ACH and SMS.